FDA Inspection 1233031 — Eurofins BioPharma Product Testing Sweden AB
The FDA completed an inspection of Eurofins BioPharma Product Testing Sweden AB on Dec 8, 2022 in Uppsala. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 8, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uppsala (Sweden)
Additional details
Mutual Recognition Agreement (MRA)